Cultivar Holdings wholly-owned Canadian subsidiary is Canadian Clinical Cannabinoids Inc. (CCC). CCC is a Licensed Producer and home of the Cannabis Innovation Centre. Starting with cultivation and analytical testing, CCC is intent on being the preferred industry partner for genomic profiling, extraction, purification, processing, and research and development.
Cultivar Holding's vision is to be a global leader in every aspect of cannabis related businesses. Our businesses range from development of cannabis derived products with clinical efficacy to artificial intelligence based solutions to detect cannabis impairment
Cannabis products became legal for recreational purposes in Canada on October 17, 2018.
According to a May, 2018 report by CIBC, the non-medical/recreational marijuana market could generate close to $6.5 billion in retail sales by 2020, exceeding the $5.1 billion that Canadians spent on spirits in 2017 and coming close to the $7 billion spent on wine.
By 2024, the size of the recreational market is estimated to be between $6.2 billion and $9.8 billion (source: D. Pearlstein; A. Sutton. (2017). The Value Case for Investing in Cannabis).
Since Canada is the first Group of Seven country to legalize the drug for recreational use, it is ideally primed to supply other international markets that are on the cusp of legalizing cannabis as well. For example, Spain, Italy, and Colombia.
Cultivator Holding recognizes that significant achievements depend on partnership and collaboration, and we are committed to working with the best and brightest innovators in the medicinal cannabis eco-system. Our partner relationships with healthcare practitioners, researchers, academic institutions, advocacy groups and patients are built on a combination of fact-based research, collaboration and compassion.
At the core of everything we do is a simple goal: heal humanity. That focus drives our relationships with our medical partners as we pursue the development of solutions for our patients that improve their quality of life.
Cultivar Holdings will be a vertically integrated supplier of pharmaceutical, nutraceutical, topical, edible, beverage and consumable medical and recreational products.
The medicinal benefits can be personalized to a customer's preference by supplying specific THC and CBD blends and concentrations.
To receive more information about the company, click the button below: